TrialBritish journal of cancer2024

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.

Patrick M Boland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.